What is Sonogen (Canada)?
Sonogen Medical, based in Baltimore, Md., is a medical device company dedicated to the development and commercialization of an ultrasonic bone fracture healing device. The company's proprietary technology leverages therapeutic ultrasound signals to promote bone growth, offering a reliable, economical, and effective solution for patients experiencing non-healing bone fractures. This innovative approach positions Sonogen Medical at the forefront of orthopedic regenerative medicine, addressing a critical unmet need in patient care and recovery.
How much funding has Sonogen (Canada) raised?
Sonogen (Canada) has raised a total of $200K across 1 funding round:
Angel/Seed
$200K
Angel/Seed (2024): $200K with participation from Tedco
Key Investors in Sonogen (Canada)
Tedco
TEDCO, the Maryland Technology Development Corporation, is an organization focused on fostering an inclusive entrepreneurial innovation ecosystem to enhance economic empowerment growth. They invest in and support technology and life science-based companies within Maryland.
What's next for Sonogen (Canada)?
With the recent influx of $200K in a major strategic investment, Sonogen Medical is poised for accelerated growth and market penetration. This substantial capital infusion, contributing to a total funding of $200K, will likely be directed towards advancing clinical trials, expanding manufacturing capabilities, and broadening its commercial reach. The company's focus on a novel ultrasonic healing device suggests a strategic direction aimed at disrupting traditional orthopedic treatment paradigms and establishing a dominant market presence.
See full Sonogen (Canada) company page
